Lobbying Filing Details

Total Spending

$50,000

Activities

2

Lobbyists

4

Gov't Entities

6

Filing Information
Filing UUID:
3a80af6b-f283-45ff-90da-11373f2c3a5b
Type:
Q2 - 2nd Quarter - Report
Period:
2026 - 2nd Quarter (Apr 1 - June 30)
Date Posted:
July 19, 2026 at 1:54 PM
Income:
$50,000
Expenses:
$0
Document URL:
View Submission
Quick Info
  • Document Type: text/html
  • Posted By: Mike Nielsen
Registrant
CGCN GROUP, LLC

Public Affairs Consultants

Washington, District of Columbia
Client
VERTEX PHARMACEUTICALS INCORPORATED

Biopharmaceutical Company

Massachusetts, United States of America
Lobbying Activities (2)
Activity 1
Health Issues

Access to innovative non-opioid medicines.

Lobbyists (4)
  • SAM GEDULDIG
  • JILL HAMAKER
  • MRS. MARTHA BEATRICE MILLER
  • SARAH GILBERT
Government Entities (4)
  • SENATE
  • HOUSE OF REPRESENTATIVES
  • White House Office
  • Health & Human Services, Dept of (HHS)
Activity 2
Medicare/Medicaid

Access to innovative non-opioid medicines; Alternatives to PAIN, H.R. 1227; Alternatives to PAIN, S. 475.

Lobbyists (4)
  • SAM GEDULDIG
  • JILL HAMAKER
  • MRS. MARTHA BEATRICE MILLER
  • SARAH GILBERT
Government Entities (2)
  • SENATE
  • HOUSE OF REPRESENTATIVES

Source: LDA.gov, data retrieved November 9, 2026. FilingExplorer is not affiliated with LDA.gov; the Senate Office of Public Records cannot vouch for data or analyses derived from these records after retrieval.